TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7899036

Group type: EXPERIMENTAL
Intervention: RDKs with varying frame durations
Number of subjects: 0

Group type: COMPARATOR
Intervention: RDKs with varying displacement sizes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RDKs with varying speeds
Number of subjects: 0
Study: 3300128

Group type: EXPERIMENTAL
Intervention: CSII
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSII and MI
Number of subjects: 0
Study: 30892498

Group type: EXPERIMENTAL
Intervention: Night shift workers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smokers or former smokers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consumers or former consumers of alcoholic beverages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Employees with higher education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Residents in the company's headquarter city
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individuals with better Brazilian economic classification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 0
Study: 28153755

Group type: EXPERIMENTAL
Intervention: Buffered 1% lidocaine with 1:100,000 epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-buffered 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 0
Study: 25372774

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU vitamin D3 pearl, 2 times during the study: at baseline and day 21)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (2 placebos at baseline and day 21)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 23759804

Group type: EXPERIMENTAL
Intervention: Classification system guided postural intervention (CSPI)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Generalized postural intervention (GPI)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CSPI
Number of subjects: 49

Group type: COMPARATOR
Intervention: GPI
Number of subjects: 49
Study: 21158953

Group type: EXPERIMENTAL
Intervention: 250 mg of ascorbic acid (AA)/kg diet
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Increasing metabolizable energy (ME) level by oil supplementation
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Increasing ME with or without essential amino acids (EAA)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Positive control (thermo-neutral conditions with corn-soybean meal diet)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Negative control (corn-soybean meal diet without supplementation)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Increasing Met, Lys and Arg concentration
Number of subjects: 420
Study: 18200351

Group type: EXPERIMENTAL
Intervention: Smokers recruited for a smoking cessation clinical trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: General smoking population in Rio de Janeiro
Number of subjects: 0
Study: 16643264

Group type: EXPERIMENTAL
Intervention: Intervention (immediate feedback about self-reported psychosocial well-being)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no immediate feedback)
Number of subjects: 80
Study: 12805552

Group type: EXPERIMENTAL
Intervention: Sequential presentation of the stimulus at one location
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random presentation of the stimulus location
Number of subjects: 0
Study: 10396219

Group type: EXPERIMENTAL
Intervention: 3D irradiation technique
Number of subjects: 9

Group type: COMPARATOR
Intervention: 2D irradiation technique (simulated)
Number of subjects: 9
Study: 7742084

Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3 treatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: Glucocorticoids and mineralocorticoids
Number of subjects: 75
Study: 2043077

Group type: EXPERIMENTAL
Intervention: Antibiotic rinse/storage (neomycin‐polymyxin B‐gramicidin)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: 1% povidone‐iodine immersion
Number of subjects: 76

Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 76
Study: 7028312

Group type: EXPERIMENTAL
Intervention: Cimetidine (Tagamet)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Promethazine hydrochloride (Phenergan)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cimetidine and Promethazine combination
Number of subjects: 20
Study: 30006513

Group type: EXPERIMENTAL
Intervention: 30g whey protein (120 kcal)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 70g whey protein (280 kcal)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Flavoured-water control drink (2 kcal)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Whey protein ingestion
Number of subjects: 16
Study: 26853238

Group type: EXPERIMENTAL
Intervention: Mini-trampoline exercise (50 minutes, moderate-to-high intensity 70-85% HRmax)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 24
Study: 24126895

Group type: EXPERIMENTAL
Intervention: NaHCO3 (0.3 g·kg(‐1) body mass)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (sodium chloride NaCl: 0.045 g·kg(‐1) body mass)
Number of subjects: 8
Study: 22581634

Group type: EXPERIMENTAL
Intervention: Endoscopic DCR with double posteriorly based nasal and lacrimal flaps
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional endoscopic DCR
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 74
Study: 20543025

Group type: EXPERIMENTAL
Intervention: Conversation intervention (500 min of linguistically and cognitively complex talk over 10 weeks, 25 min twice weekly)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 73
Study: 18789068

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser treatment
Number of subjects: 120
Study: 15954115

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (300 mJ/pulse, 10 Hz, defocused mode)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CO2 laser (4-6 W, 20-50 Hz, focused mode)
Number of subjects: 10
Study: 12028854

Group type: EXPERIMENTAL
Intervention: 4 or 8 mg/day of buprenorphine
Number of subjects: 23
Study: 10051269

Group type: EXPERIMENTAL
Intervention: AERO + ST
Number of subjects: 45

Group type: COMPARATOR
Intervention: AERO
Number of subjects: 45
Study: 7670648

Group type: EXPERIMENTAL
Intervention: ACE-inhibitor (n = 135)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Calcium-antagonist (n = 131)
Number of subjects: 266

Group type: COMPARATOR
Intervention: ACE-inhibitor and Calcium-antagonist
Number of subjects: 266
Study: 2166885

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS) 4 mg four times daily
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BD) 0.1 mg four times daily
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 6269038

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 100

Group type: COMPARATOR
Intervention: Barrier methods (foam, condom, and/or diaphragm)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Barrier methods
Number of subjects: 100
Study: 30259346

Group type: EXPERIMENTAL
Intervention: Active visualisation intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard care (including adherence counselling)
Number of subjects: 111
Study: 26780267

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification Training (ABMT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Attention Control Training (ACT)
Number of subjects: 99
Study: 24799354

Group type: EXPERIMENTAL
Intervention: Direct mailings
Number of subjects: 237

Group type: COMPARATOR
Intervention: Newspaper advertisements
Number of subjects: 237

Group type: COMPARATOR
Intervention: Community outreach
Number of subjects: 237
Study: 24291230

Group type: EXPERIMENTAL
Intervention: Patella denervation (n = 63)
Number of subjects: 126

Group type: COMPARATOR
Intervention: No patella denervation (n = 63)
Number of subjects: 126
Study: 22155939

Group type: EXPERIMENTAL
Intervention: Stress condition (Trier Social Stress Test)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control condition (placebo TSST)
Number of subjects: 232
Study: 20850800

Group type: EXPERIMENTAL
Intervention: Longitudinal brain MRI studies
Number of subjects: 0
Study: 17400089

Group type: EXPERIMENTAL
Intervention: PS implants designed for increased flexion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard posterior-stabilized (PS) implants
Number of subjects: 20
Study: 16350714

Group type: EXPERIMENTAL
Intervention: 1alpha‐OHD3 (0.5 microg/d) and calcium carbonate (1 g daily)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Complete androgenic blockade (orchidectomy + flutamide 750 mg daily)
Number of subjects: 51
Study: 11874926

Group type: COMPARATOR
Intervention: Diet Only (DO)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Diet and Aerobic Exercise (DA)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Diet and Resistance Exercise (DR)
Number of subjects: 38
Study: 10440140

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 3117

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 3117

Group type: COMPARATOR
Intervention: Defibrillator
Number of subjects: 3117
Study: 1729065

Group type: EXPERIMENTAL
Intervention: Dobutamine (5 micrograms/kg/min)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Amrinone (2.25 mg/kg bolus + 20 micrograms/kg/min)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Calcium infusion
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 46
Study: 6741156

Group type: EXPERIMENTAL
Intervention: Sustained release theophylline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional prolonged-action theophylline-ethylenediamine preparation
Number of subjects: 0
Study: 31248307

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (233 mg zinc gluconate containing 30 mg zinc) for 10 weeks
Number of subjects: 52
Study: 31464855

Group type: EXPERIMENTAL
Intervention: Femoral neck shortening (measured as a categorical variable: no shortening, mild shortening (≤5 mm), moderate shortening (6‐10 mm), severe shortening (>10 mm))
Number of subjects: 350
Study: 29224639

Group type: EXPERIMENTAL
Intervention: Ultrasound-based renal denervation (Paradise)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Renal angiogram (sham)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard of care medication
Number of subjects: 0
Study: 26742777

Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg/day in combination with allopurinol
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Lesinurad 400 mg/day in combination with allopurinol
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Lesinurad 600 mg/day in combination with allopurinol
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo in combination with allopurinol
Number of subjects: 227
Study: 26265792

Group type: EXPERIMENTAL
Intervention: Modified high-intensity interval training (HIIT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 23720096

Group type: EXPERIMENTAL
Intervention: Individualized education intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study: 20624069

Group type: EXPERIMENTAL
Intervention: Zidovudine + lamivudine + efavirenz (group A)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Zidovudine + lamivudine + ritonavir-boosted indinavir (group B)
Number of subjects: 65
Study: 17906313

Group type: EXPERIMENTAL
Intervention: Tailored injury prevention information (T‐IPI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored injury prevention information (T‐IPI) supplemented with a tailored summary for providers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic injury prevention information
Number of subjects: 0
Study: 16467063

Group type: EXPERIMENTAL
Intervention: Cardica PAS-port aortic connector
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hand-sewn technique
Number of subjects: 24
Study: 14967866

Group type: EXPERIMENTAL
Intervention: 8% CHOexo (1 g glucose x kg x h(‐1))
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (artificially sweetened)
Number of subjects: 14
Study: 10758775

Group type: EXPERIMENTAL
Intervention: Test formulation (Azectol)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 17
Study: 9209643

Group type: EXPERIMENTAL
Intervention: Long-range nested polymerase chain reaction (PCR) using 0.5 microgram of DNA (60,000-80,000 cells)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Long-range PCR
Number of subjects: 144
Study: 8209462

Group type: EXPERIMENTAL
Intervention: Rhythmilen, ethacirine, ethmorin with allapinin
Number of subjects: 0
Study: 3040918

Group type: EXPERIMENTAL
Intervention: Vindesine (VDS)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Lomustine (CCNU), Cyclophosphamide (CTX), Methotrexate (MTX)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: All four drugs (VDS, CCNU, CTX, MTX)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Patients with dose‐limiting toxicity
Number of subjects: 279
Study: 30024485

Group type: EXPERIMENTAL
Intervention: Hyperoxia (PER)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Hypoxia (HY)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normoxia (Control)
Number of subjects: 11
Study: 28771657

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 6119
Study: 26928185

Group type: EXPERIMENTAL
Intervention: Electromyography-guided femoral nerve block (FNB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intraoperative periarticular injection (PAI)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined FNB and PAI
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study: 25536736

Group type: EXPERIMENTAL
Intervention: 5-mm titanium clips
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Plasma Trisector (Gyrus, USA) (PTG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Surgical silk
Number of subjects: 100
Study: 22494081

Group type: EXPERIMENTAL
Intervention: Peer group (PG) feedback
Number of subjects: 73

Group type: COMPARATOR
Intervention: Practice visit (PV) feedback
Number of subjects: 73
Study: 20150283

Group type: EXPERIMENTAL
Intervention: Intensive therapy (INT)
Number of subjects: 1211

Group type: COMPARATOR
Intervention: Conventional therapy (CON)
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Intensive therapy (INT) in adolescents
Number of subjects: 1211

Group type: COMPARATOR
Intervention: Conventional therapy (CON) in adolescents
Number of subjects: 1211
Study: 17901414

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 16030027

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Combination of Anastrozole and Tamoxifen
Number of subjects: 176
Study: 12598237

Group type: EXPERIMENTAL
Intervention: pH-stat
Number of subjects: 52

Group type: COMPARATOR
Intervention: alpha-stat
Number of subjects: 52
Study: 10230948

Group type: EXPERIMENTAL
Intervention: Low-dose propofol infusion (1 mg/kg/h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-dose propofol infusion
Number of subjects: 30
Study: 8678276

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Enflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane and Enflurane
Number of subjects: 30
Study: 1524328

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract using cefotaxime (1 g IV every 8 hours for the first 3 days) and oral nonabsorbable antibiotics (gentamicin, polymyxin, and nystatin) for the entire stay in the ICU
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract
Number of subjects: 150
Study: 6231062

Group type: EXPERIMENTAL
Intervention: Micronized etodolac in capsule and tablet forms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular etodolac dosage forms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etodolac with food
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etodolac with antacid (magaldrate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etodolac with antiulcer agent (sucralfate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single bolus dose or divided (b.i.d.) doses of etodolac in man
Number of subjects: 0
Study: 31697698

Group type: EXPERIMENTAL
Intervention: GOAL program (twice weekly group sessions for 10 weeks, 20 sessions)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Services as usual (non-gender-specific aggression management training, individual counseling, and no services)
Number of subjects: 87
Study: 28482678

Group type: EXPERIMENTAL
Intervention: Partnerships for Active Children in Elementary Schools intervention
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 229
Study: 27322638

Group type: EXPERIMENTAL
Intervention: Blood alcohol concentration (BAC) of approx. 0.5g/L
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Blood alcohol concentration (BAC) of approx. 0.9g/L
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sober driving
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Repeated simulator exposures
Number of subjects: 20
Study: 25487965

Group type: EXPERIMENTAL
Intervention: Laser-assisted surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional surgery using scalpels (Control)
Number of subjects: 30
Study: 22276680

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) plus HAART for 16 weeks followed by HAART alone for 32 weeks (arm 1; n = 27)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: HAART alone for 16 weeks and then VPA plus HAART for 32 weeks (arm 2; n = 29)
Number of subjects: 56
Study: 19255158

Group type: EXPERIMENTAL
Intervention: Monthly intravitreal ranibizumab (0.3 or 0.5 mg)
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Sham injections (control group in MARINA)
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Monthly ranibizumab (0.3 or 0.5 mg) with sham photodynamic therapy (PDT)
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Sham ocular injections with verteporfin PDT (control group in ANCHOR)
Number of subjects: 1139
Study: 17720114

Group type: EXPERIMENTAL
Intervention: HPbetaCD diclofenac sodium 75 mg
Number of subjects: 155

Group type: COMPARATOR
Intervention: PG‐BA diclofenac sodium 75 mg
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: HPbetaCD diclofenac sodium
Number of subjects: 155

Group type: COMPARATOR
Intervention: PG‐BA diclofenac sodium
Number of subjects: 155
Study: 15049727

Group type: EXPERIMENTAL
Intervention: True ultrasound (US)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham ultrasound (US)
Number of subjects: 40
Study: 12421175

Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg orally + Misoprostol 0.4 mg vaginally (Mf + Ms)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Misoprostol 0.4 mg vaginally (Ms)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Surgical Evacuation (SE)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 176
Study: 9871426

Group type: COMPARATOR
Intervention: Fexofenadine hydrochloride (single doses of 10 to 800 mg)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Fexofenadine hydrochloride (multiple doses of 20 to 690 mg twice daily for 28 1/2 days)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 9098461

Group type: EXPERIMENTAL
Intervention: GnRH analogue from mid-luteal phase (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: GnRH analogue in the follicular phase (flare-up) (Group B)
Number of subjects: 100
Study: 2230555

Group type: EXPERIMENTAL
Intervention: Electro-cautery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemical cautery with silver nitrate
Number of subjects: 0
Study: 977791

Group type: EXPERIMENTAL
Intervention: Chlordesmethyldiazepam (2 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chlordesmethyldiazepam (1 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chlordesmethyldiazepam (plasma concentrations)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Amylobarbitone (plasma concentrations)
Number of subjects: 8
Study: 31778585

Group type: EXPERIMENTAL
Intervention: LEAP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 31220991

Group type: EXPERIMENTAL
Intervention: Four-step tapering (DRESS strategy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Five-step tapering
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapering without withdrawal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of a stricter flare criterion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of a theoretical predictor for successful tapering
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuation of treatment
Number of subjects: 0
Study: 28601342

Group type: EXPERIMENTAL
Intervention: Local excision
Number of subjects: 145

Group type: COMPARATOR
Intervention: Total mesorectal excision
Number of subjects: 145
Study: 26080888

Group type: EXPERIMENTAL
Intervention: Modified primary root canal filling (MPRCF)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Zinc oxide‐eugenol cement (ZOE)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Calcium hydroxide/iodoform paste (Vitapex)
Number of subjects: 160
Study: 23556546

Group type: EXPERIMENTAL
Intervention: Use of diagnostic resources (knowledge sources, such as forms in the PES format or an assessment format)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prestructured forms
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Use of certain kinds of diagnostic resources
Number of subjects: 60